Reta glucagon-like peptide-1 (GLP-1) receptor agonists offer a groundbreaking approach to diabetes management. These innovative medications work by mimicking the physiological actions of GLP-1, a hormone released by the https://darrenhzvm801902.ivasdesign.com/60155129/glp-1-receptor-agonists-as-a-novel-therapy-for-diabetes